Human Chorionic Gonadotropin (hCG) Market To Receive Overwhelming Hike in Revenues By 2030
                     Human Chorionic Gonadotropin (hCG) 
Market To Receive Overwhelming Hike in 
Revenues By 2030
Human Chorionic Gonadotropin (hCG) Market by Technology (Natural Source Extraction, and Recombinant Technology), 
Therapeutic Area (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment, and Others), and End User 
(Fertility Clinics, Research Institutes, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2025
Why Allied Market Research?
FREQUENTLY ASKED QUESTIONS?
INFALLIBLE METHODOLOGY
To ensure high-level data integrity, accurate analysis, and Q1. Who are the leading market players active 
impeccable forecasts in the Human Chorionic Gonadotropin (hCG) 
ANALYST SUPPORT Market?
For complete satisfaction Q2. What are the current trends that will 
influence the market in the next few years?
CUSTOMIZATION
Q3. What are the driving factors, restraints, and 
On-demand customization of scope of the report to exactly meet opportunities in the market?
your needs
Q4. What can be the challenges for the Human 
TARGETED MARKET VIEW
Chorionic Gonadotropin (hCG) Market in future?
Targeted market view to provide pertinent information and save Q5. Does the Human Chorionic Gonadotropin 
time of readers
(hCG) Market company is profiled in the report?
Overview
Rise in incidence of infertility-related problems in both the genders 
drive the growth of the global hCG market. In addition, upsurge in 
the adoption of hCG hormone in pain management and weight loss 
propel the market growth. Furthermore, incorporation of recombinant 
technology for the development of hCG is anticipated to offer 
lucrative opportunities for the market growth in the near future.
Based on technology, the market is divided into natural source 
extraction and recombinant technology. The recombinant technology 
segment is expected to register the highest growth rate during the 
forecast period. However, the natural source extraction segment 
dominated the global market in 2017 and is anticipated to remain 
dominant throughout the forecast period. This is attributed to easy 
and low-cost availability of hCG from pregnant womens urine and 
placenta cells.
Segments
In terms of revenue, the global Human Chorionic Gonadotropin (hCG) Market is segmented on the basis of Technology, Therapeutic Area, End 
Users, and Regions.  
By Technology - Based on technology, the market is divided into 
natural source extraction and recombinant technology. The 
recombinant technology segment is expected to register the highest 
growth rate during the forecast period. However, the natural source 
extraction segment dominated the global market in 2017 and is 
anticipated to remain dominant throughout the forecast period.
By Therapeutic Area - Based on the therapeutic area, the global 
market is classified into female infertility treatment, oligospermic 
treatment, male hypogonadism, and others. Male hypogonadism 
segment is anticipated to witness highest growth rate in the global 
market, owing to high susceptibility of geriatric population to 
hypogonadism. 
Geography
North America dominated the Human Chorionic 
Gonadotropin (hCG) Market. The market growth in 
North America is primarily a reflection of product 
innovations and launches resulting from 
technological advancements. The companies mostly 
adopted product launch, acquisition, and expansion 
as their key strategies to keep pace with the 
changing demands of consumers and strengthen 
their market position.
Key Market Players
The key players operating in the global Human Chorionic Gonadotropin (hCG) Market are
• Bristol Myers Squibb Company
• Ferring Pharmaceuticals Inc
• Merck & Co., Inc
• Fresenius Kabi AG
• Cigna
• Sun Pharmaceutical Industries Ltd
• Lee BioSolutions Inc
• Sanzyme
• Scripps Laboratories
• LUPIN
• An in-depth market analysis includes analysis of various 
regions, which is anticipated to provide a detailed 
understanding of the current trends to enable stakeholders 
Key Findings of the formulate region-specific plans.
Human Chorionic • A comprehensive analysis of factors that drive and restrain 
Gonadotropin (hCG) the growth of the global is provided.
• The projections in this report are made by analyzing the 
Market:
current trends and future market potential from 2021 to 
2030, in terms of value.
Find out more at the Allied Market Report store
https://www.alliedmarketresearch.com/human-chorionic-gonadotropin-HCG-market